Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.

Item

http://www.wikidata.org/entity/Q36427789

Q36427789

about

Validation of functional imaging as a biomarker for radiation treatment response The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.Predicting response to neoadjuvant therapy in esophageal cancer.Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer.Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics Early response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer.Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal Cancer The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation.Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer Value of sequential 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in prediction of the overall survival of esophageal cancer patients treated with chemoradiotherapy.Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.Computerized PET/CT image analysis in the evaluation of tumour response to therapy.18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus The 100 most cited articles investigating the radiological staging of oesophageal and junctional cancer: a bibliometric analysis.Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation:a systematic review and meta-analysis.Oesophageal cancer--an overview.Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation.The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial.Potentially Curable Cancers of the Esophagus and Stomach.Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma.Positron Emission Tomography's Utility in Esophageal Cancer Management Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer.Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.Radiotherapy for esophageal carcinoma: dose, response and survival.Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus.Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma.Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

P2860

Q26823165-34220BFC-06BE-45BB-B5CC-2268D9B765A0 Q30393722-B0426A32-673C-489F-B0CF-217EF5475FB0 Q34022135-B8FFB28F-80A9-48E0-8D48-846FAA827A64 Q34104159-590596DC-181E-4070-8069-5696056346BC Q34216771-872F485C-A722-43DF-A8A8-4871BB779E17 Q34382399-727E23BD-9AD1-40D1-8863-38FD80384971 Q34390923-95B12957-8C46-46A1-A342-6EAE946BC25B Q34488764-9C3B9A9C-4D43-4D65-AAB1-9D699EBB4F46 Q34521659-1043841A-63C4-4FEE-BDF0-EC4A14D50F77 Q34978457-633A7717-1DA0-431B-8A89-B3D05592DA75 Q35332601-D3EAF228-2718-4928-9F34-A4B94429E63E Q35445146-4BCD34E4-DD47-45E3-B848-FC2C84263F1C Q35769322-DC14B41B-4D81-4313-9DE9-C8B4A4D6F43E Q35922472-17EE093A-1AE6-40DF-9070-76E48EC2FE7F Q36022348-EC51A08C-8058-45FE-A1AD-BE6E5AF45F00 Q36032993-6FCC9B5D-F2A5-42D0-8950-75FA1DD3CA50 Q36046360-536CAF38-A3D2-4248-AC55-53358E0B0AC7 Q36074242-527C6B26-9DED-4D0F-A569-2FC9731C1105 Q36295403-F8BA6ADD-5BCF-4130-BA86-367B26740EEF Q36328330-B3238DAE-58BF-47DF-94A9-F2EA2EC9207C Q36623646-9A2040DD-7629-409C-B5A6-11351609F3CC Q37116282-78DF2EEB-0962-47AF-A391-B63C343E0C28 Q37161611-A7F87D7A-7BFF-4C49-9AF3-2B52308D4014 Q37203302-1FDD7950-AF31-4107-8F14-0EB273C569D1 Q37984273-59E57C07-6CA3-4203-BAA6-500E6385877B Q38072285-E91E3D44-1CDA-4C3E-A16F-ECF75AFA3DDD Q38173366-E684DECA-F0A5-4411-AB5F-40DE592A3F51 Q38226697-D90FB0DC-FF88-4004-9ADD-BE1E7E6E8A27 Q38325752-F4A8C373-B511-4F87-9CB4-32C69A7C6AB0 Q38466083-B7BC1D4C-5464-4EB0-ABAE-0249265487BA Q38824375-CB76410B-97AF-4C3C-AAC4-96DA9D9DBA00 Q40098156-46F8C149-6C79-400D-839C-6B5283D5FEA6 Q40341515-2BD4A8FC-09CE-4F76-A53E-E45F9BF19963 Q43766249-831FFEA9-84E9-4DAC-8E0F-7B30546CD290 Q45075447-D58CB07E-866B-4107-9E7F-FF3011195B45 Q49147470-015D8CC9-33B2-4A8A-8D4C-B0B6260A2D82 Q49166159-DA3FE04B-B36F-48B6-A9AF-E75B80BEDA16 Q52973472-19DD7F31-CA50-40D5-BE4B-1259D21D5187 Q53059540-890FE291-9AE9-4E89-8409-FA68AE287293 Q53086769-F23182A2-A21E-4379-8C08-2C2F47604E91

P2860

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.

Item

http://www.wikidata.org/entity/Q36427789

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@ast

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@en

type

Item

label

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@ast

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@en

prefLabel

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@ast

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@en

P1476

Predictive value of 18-fluoro- ...... ly advanced esophageal cancer.

@en

P2093

A William Blackstock

http://www.w3.org/2001/XMLSchema#string

Coty Ho

http://www.w3.org/2001/XMLSchema#string

Edward A Levine

http://www.w3.org/2001/XMLSchema#string

Girish Mishra

http://www.w3.org/2001/XMLSchema#string

James Lovato

http://www.w3.org/2001/XMLSchema#string

Kim R Geisinger

http://www.w3.org/2001/XMLSchema#string

Michael R Farmer

http://www.w3.org/2001/XMLSchema#string

Paige Clark

http://www.w3.org/2001/XMLSchema#string

Susan A Melin

http://www.w3.org/2001/XMLSchema#string

Tim Oaks

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.

Downstaging of esophageal cancer after preoperative radiation and chemotherapy.

Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy v

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.

P304

472-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.SLA.0000208430.07050.61

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

243

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7227238

http://www.w3.org/2001/XMLSchema#string

P698

16552197

http://www.w3.org/2001/XMLSchema#string

P921

glucose

chemoradiotherapy

glycobiology

P932

1448953

http://www.w3.org/2001/XMLSchema#string

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.

about

P2860

P2860

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932